Citation: Kd. Rittenhouse et al., EVALUATION OF MICRODIALYSIS SAMPLING OF AQUEOUS-HUMOR FOR IN-VIVO MODELS OF OCULAR ABSORPTION AND DISPOSITION, Journal of pharmaceutical and biomedical analysis, 16(6), 1998, pp. 951-959
Citation: Sp. Letrent et al., EFFECT OF GF120918, A POTENT P-GLYCOPROTEIN INHIBITOR, ON MORPHINE PHARMACOKINETICS AND PHARMACODYNAMICS IN THE RAT, Pharmaceutical research, 15(4), 1998, pp. 599-605
Citation: Pl. Golden et Gm. Pollack, RATIONALE FOR INFLUX ENHANCEMENT VERSUS EFFLUX BLOCKADE TO INCREASE DRUG EXPOSURE TO THE BRAIN, Biopharmaceutics & drug disposition, 19(4), 1998, pp. 263-272
Authors:
SCHROEDER TJ
CHO MJ
POLLACK GM
FLOCH R
MORAN HB
LEVY R
MOORE LW
POULETTY P
Citation: Tj. Schroeder et al., COMPARISON OF 2 CYCLOSPORINE FORMULATIONS IN HEALTHY-VOLUNTEERS - BIOEQUIVALENCE OF THE NEW SANG-35 FORMULATION AND NEORAL, Journal of clinical pharmacology, 38(9), 1998, pp. 807-814
Citation: Cp. Chen et Gm. Pollack, ALTERED DISPOSITION AND ANTINOCICEPTION OF [D-PENICILLAMINE(2,5)] ENKEPHALIN IN MDR1A-GENE-DEFICIENT MICE, The Journal of pharmacology and experimental therapeutics, 287(2), 1998, pp. 545-552
Authors:
CHEN CP
JEFFERY D
JORGENSON JW
MOSELEY MA
POLLACK GM
Citation: Cp. Chen et al., SENSITIVE ANALYSIS OF [D-PEN(2,5)]ENKEPHALIN IN RAT SERUM BY CAPILLARY ELECTROPHORESIS AND LASER-INDUCED FLUORESCENCE DETECTION, Journal of chromatography B. Biomedical sciences and applications, 697(1-2), 1997, pp. 149-162
Authors:
NOLTING A
DELONG RK
FISHER MH
WICKSTROM E
POLLACK GM
JULIANO RL
BROUWER KLR
Citation: A. Nolting et al., HEPATIC DISTRIBUTION AND CLEARANCE OF ANTISENSE OLIGONUCLEOTIDES IN THE ISOLATED-PERFUSED RAT-LIVER, Pharmaceutical research, 14(4), 1997, pp. 516-521
Citation: Cp. Chen et Gm. Pollack, EXTENSIVE BILIARY-EXCRETION OF THE MODEL OPIOID PEPTIDE [D-PEN(2,5)] ENKEPHALIN IN RATS, Pharmaceutical research, 14(3), 1997, pp. 345-350
Citation: Kd. Rittenhouse et al., EXAMINATION OF THE ABSORPTION AND INTRAOCULAR DISPOSITION OF A MODEL BETA-ADRENERGIC ANTAGONIST USING MICRODIALYSIS, Investigative ophthalmology & visual science, 38(4), 1997, pp. 698-698
Citation: Xr. Liu et al., A MODIFIED RESIDUAL METHOD TO ESTIMATE THE ZERO-ORDER ABSORPTION RATE-CONSTANT IN A ONE-COMPARTMENT MODEL, Biopharmaceutics & drug disposition, 18(2), 1997, pp. 93-101
Authors:
TROY SM
PARKER VP
HICKS DR
POLLACK GM
CHIANG ST
Citation: Sm. Troy et al., PHARMACOKINETICS AND EFFECT OF FOOD ON THE BIOAVAILABILITY OF ORALLY-ADMINISTERED VENLAFAXINE, Journal of clinical pharmacology, 37(10), 1997, pp. 954-961
Authors:
WARD KW
BLUMENTHAL GM
WELSCH F
POLLACK GM
Citation: Kw. Ward et al., DEVELOPMENT OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL TO DESCRIBE THE DISPOSITION OF METHANOL IN PREGNANT RATS AND MICE, Toxicology and applied pharmacology, 145(2), 1997, pp. 311-322
Authors:
LIN PH
WAIDYANATHA S
POLLACK GM
RAPPAPORT SM
Citation: Ph. Lin et al., DOSIMETRY OF CHLORINATED QUINONE METABOLITES OF PENTACHLOROPHENOL IN THE LIVERS OF RATS AND MICE BASED UPON MEASUREMENT OF PROTEIN ADDUCTS, Toxicology and applied pharmacology, 145(2), 1997, pp. 399-408
Citation: Cp. Chen et Gm. Pollack, BLOOD-BRAIN DISPOSITION AND ANTINOCICEPTIVE EFFECTS OF [D-PENICILLAMINE(2,5)]ENKEPHALIN IN THE MOUSE, The Journal of pharmacology and experimental therapeutics, 283(3), 1997, pp. 1151-1158
Citation: Dmc. Ouellet et Gm. Pollack, PHARMACODYNAMICS AND TOLERANCE DEVELOPMENT DURING MULTIPLE INTRAVENOUS BOLUS MORPHINE ADMINISTRATION IN RATS, The Journal of pharmacology and experimental therapeutics, 281(2), 1997, pp. 713-720
Citation: Dmc. Ouellet et Gm. Pollack, EFFECT OF PRIOR MORPHINE-3-GLUCURONIDE EXPOSURE ON MORPHINE DISPOSITION AND ANTINOCICEPTION, Biochemical pharmacology, 53(10), 1997, pp. 1451-1457
Citation: Cp. Chen et Gm. Pollack, DEVELOPMENT OF A CAPILLARY ZONE ELECTROPHORESIS ASSAY TO EXAMINE THE DISPOSITION OF [D-PEN(2,5)]ENKEPHALIN IN RATS, Journal of chromatography B. Biomedical applications, 681(2), 1996, pp. 363-373
Citation: Ra. Perkins et al., VENTILATION OF AMBULATORY RATS EXPOSED TO METHANOL VAPOR IN A FLOW-THROUGH EXPOSURE SYSTEM - MEASUREMENT AND INPUT TO TOXICOKINETIC MODELS, Inhalation toxicology, 8(2), 1996, pp. 143-162
Citation: Ra. Perkins et al., METHANOL INHALATION - SITE AND OTHER FACTORS INFLUENCING ABSORPTION, AND AN INHALATION TOXICOKINETIC MODEL FOR THE RAT, Pharmaceutical research, 13(5), 1996, pp. 749-755
Citation: Cl. Booth et al., HEPATOBILIARY DISPOSITION OF VALPROIC ACID AND VALPROATE GLUCURONIDE - USE OF A PHARMACOKINETIC MODEL TO EXAMINE THE RATE-LIMITING STEPS AND POTENTIAL SITES OF DRUG-INTERACTIONS, Hepatology, 23(4), 1996, pp. 771-780
Citation: Cp. Chen et al., INFLUENCE OF AGE AND GENDER ON VALPROIC ACID GLUCURONIDATION IN RATS, Drug metabolism and disposition, 24(3), 1996, pp. 367-370
Citation: Kw. Ward et Gm. Pollack, COMPARATIVE TOXICOKINETICS OF METHANOL IN PREGNANT AND NONPREGNANT RODENTS, Drug metabolism and disposition, 24(10), 1996, pp. 1062-1070
Citation: Kw. Ward et Gm. Pollack, USE OF INTRAUTERINE MICRODIALYSIS TO INVESTIGATE METHANOL-INDUCED ALTERATIONS IN UTEROPLACENTAL BLOOD-FLOW, Toxicology and applied pharmacology, 140(2), 1996, pp. 203-210
Citation: J. Gaudreault et al., ANTICONVULSANT PHARMACODYNAMICS AND DISPOSITION OF TRIAZOLAM IN RATS, Journal of pharmaceutical sciences, 85(9), 1996, pp. 999-1004
Citation: Ld. Carlton et al., PHYSIOLOGICAL PHARMACOKINETIC MODELING OF GASTROINTESTINAL BLOOD-FLOWAS A RATE-LIMITING STEP IN THE ORAL ABSORPTION OF DIGOXIN - IMPLICATIONS FOR PATIENTS WITH CONGESTIVE-HEART-FAILURE RECEIVING EPOPROSTENOL, Journal of pharmaceutical sciences, 85(5), 1996, pp. 473-477